BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 19809879)

  • 1. Identification and treatment of metabolic complications in pediatric obesity.
    Ode KL; Frohnert BI; Nathan BM
    Rev Endocr Metab Disord; 2009 Sep; 10(3):167-88. PubMed ID: 19809879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Consequences of Pediatric Obesity: A Review of Pathophysiology, Screening, and Treatment.
    Gunaratne N; Deplewski D
    Pediatr Ann; 2023 Feb; 52(2):e62-e67. PubMed ID: 36779885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease.
    Baranova A; Tran TP; Birerdinc A; Younossi ZM
    Aliment Pharmacol Ther; 2011 Apr; 33(7):801-14. PubMed ID: 21251033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
    Jeanes YM; Reeves S
    Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Insulin resistance/hyperinsulinemia associated diseases not included in the metabolic syndrome].
    Carvalheira JB; Saad MJ
    Arq Bras Endocrinol Metabol; 2006 Apr; 50(2):360-7. PubMed ID: 16767302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic complications of obesity in childhood and adolescence: more than just diabetes.
    Nathan BM; Moran A
    Curr Opin Endocrinol Diabetes Obes; 2008 Feb; 15(1):21-9. PubMed ID: 18185059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of the endocrine system in the pathogenesis of non-alcoholic fatty liver disease].
    Hagymási K; Reismann P; Rácz K; Tulassay Z
    Orv Hetil; 2009 Nov; 150(48):2173-81. PubMed ID: 19923096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric obesity and insulin resistance: chronic disease risk and implications for treatment and prevention beyond body weight modification.
    Cruz ML; Shaibi GQ; Weigensberg MJ; Spruijt-Metz D; Ball GD; Goran MI
    Annu Rev Nutr; 2005; 25():435-68. PubMed ID: 16011474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Obesity--significance in adolescence and for reproduction].
    Wolf AS; Sterzik K
    Zentralbl Gynakol; 1998; 120(5):210-22. PubMed ID: 9629628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of the metabolic syndrome in children.
    Steinberger J
    Curr Opin Lipidol; 2003 Dec; 14(6):555-9. PubMed ID: 14624131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for metabolic and reproductive complications in obese children and adolescents.
    Irizarry KA; Brito V; Freemark M
    Pediatr Ann; 2014 Sep; 43(9):e210-7. PubMed ID: 25198445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mutltifaceted biological roles of adiponectin].
    Cuerq C; Morineau G; Dufour-Rainfray D; Vatier C; Fellahi S; Vigouroux C; Genoux A; Lacorte JM; Charchour R; Fève B; Capeau J; Collet C; Bastard JP;
    Ann Biol Clin (Paris); 2020 Jun; 78(3):243-252. PubMed ID: 32540813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Childhood obesity.
    Sabin MA; Shield JPH
    Front Horm Res; 2008; 36():85-96. PubMed ID: 18230896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term risks of polycystic ovaries syndrome].
    Lefebvre P; Raingeard I; Renard E; Bringer J
    Gynecol Obstet Fertil; 2004 Mar; 32(3):193-8. PubMed ID: 15123116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework shift.
    Nolan CJ; Prentki M
    Diab Vasc Dis Res; 2019 Mar; 16(2):118-127. PubMed ID: 30770030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences.
    Anagnostis P; Tarlatzis BC; Kauffman RP
    Metabolism; 2018 Sep; 86():33-43. PubMed ID: 29024702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity, insulin resistance, and type 2 diabetes in children and adolescents.
    Rappaport EB; Usher DC
    Pediatr Ann; 2006 Nov; 35(11):822-6. PubMed ID: 17153129
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolic Syndrome in Polycystic Ovary Syndrome.
    Pasquali R
    Front Horm Res; 2018; 49():114-130. PubMed ID: 29894990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Psoriasis With Comorbidity Development in Children With Psoriasis.
    Tollefson MM; Van Houten HK; Asante D; Yao X; Maradit Kremers H
    JAMA Dermatol; 2018 Mar; 154(3):286-292. PubMed ID: 29322175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycystic ovarian syndrome.
    Khan KA; Stas S; Kurukulasuriya LR
    J Cardiometab Syndr; 2006; 1(2):125-30; quiz 131-2. PubMed ID: 17679815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.